News About: Goverment
Foreign drugmakers to face heavy fines over rebate
The Fair Trade Commission said on November 2 that they would disclose that seven pharmaceutical companies have been offering rebates or donations to major hospitals and wholesalers under various pretexts.
Pfizer Ko...
Bioequivalence of combined preparations g to be compulsory
Korean generic makers will have to conduct bioequivalence testing over combined preparations as the Korea Food and Drug Administration intends to evaluate the efficacy and safety of these medicines.
To this end, th...
Establishment of technology holding company eyed
The government is considering establishing a technology holding company in the first half of next year to develop new technologies in collaboration with universities and government-funded research institute
The fun...
Fines on product information session is unfair, court says
A court ruled that a product information session sponsored by Yuhan Corporation was fair.
The Seoul High Court said on November that the session is not regarded as undue activity to attract customers and a 2.1 bill...
Bill proposed for pharmacists’ basic rights
A lawmaker has proposed a bill to protect pharmacists’ basic rights including establishing a pharmacy corporation composed by pharmacists only.
To protect their rights, the bill also proposes allowing the establish...
KDI criticizing bill to nurture pharmaceutical industry
The state-run Korea Development Institute (KDI) said on November 19 that the proposed bill to cultivate the local pharmaceutical industry is aimed to guarantee the benefits of a specific group under a shady deal betwe...
KFDA official hints at strengthening validation
The nation's health watchdog hinted on November 19 that its cGMP inspection would be further strengthened from next year as part of efforts to firmly establish the new GMP system.
Korea Food and Drug Administration...
Government to adopt ICH guideline over age definition
The Korea Food and Drug Administration plans to screen the age criteria based on the guideline of the International Conference on Harmonization (ICH), when it screens an application for approval of new drugs.
It ad...
R&D spending for medical and pharmaceutical colleges tops 473 billion won
Korea's research and development (R&D) spending for 4-year medical and pharmaceutical colleges reached 473.4 billion won last year, the government said on November 14.
The figure accounted for 14.4 percent of the t...
Government pricing policy over lipid-lowering medicines stirs debate
The Health Insurance Review and Assessment Service (HIRA) announced on November 12 that it will readjust the prices of lipid-lowering agents based on weighed average price of simvastatin 20 mg (838 won).
Foreign dr...
